Robeco Schweiz’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-138,769
Closed -$8.09M 156
2020
Q4
$8.09M Sell
138,769
-68,251
-33% -$4.12M 0.17% 104
2020
Q3
$13.1M Sell
207,020
-1,300
-0.6% -$90.2K 0.39% 71
2020
Q2
$16M Sell
208,320
-62,689
-23% -$4.8M 0.58% 53
2020
Q1
$20.6M Buy
271,009
+21,660
+9% +$1.5M 0.88% 40
2019
Q4
$16.2M Buy
249,349
+2,980
+1% +$194K 0.6% 59
2019
Q3
$15.5M Buy
246,369
+11,489
+5% +$751K 0.67% 54
2019
Q2
$15.8M Buy
234,880
+35,367
+18% +$2.33M 0.67% 49
2019
Q1
$13M Buy
199,513
+5,240
+3% +$348K 0.54% 54
2018
Q4
$12M Buy
194,273
+4,912
+3% +$343K 0.56% 54
2018
Q3
$14.5M Buy
189,361
+57,427
+44% +$4.34M 0.57% 57
2018
Q2
$9.28M Buy
131,934
+2,199
+2% +$155K 0.4% 74
2018
Q1
$9.78M Sell
129,735
-835
-0.6% -$66.4K 0.45% 68
2017
Q4
$9.46M Sell
130,570
-584
-0.4% -$44.3K 0.62% 60
2017
Q3
$10.6M Sell
131,154
-25,455
-16% -$1.95M 0.82% 39
2017
Q2
$11.1M Buy
156,609
+9,596
+7% +$639K 0.93% 36
2017
Q1
$9.93M Buy
147,013
+4,045
+3% +$284K 0.85% 38
2016
Q4
$10.3M Buy
142,968
+17,916
+14% +$1.33M 0.95% 32
2016
Q3
$9.74M Buy
125,052
+184
+0.1% +$14.9K 0.84% 37
2016
Q2
$10.3M Sell
124,868
-1,222
-1% -$108K 0.94% 28
2016
Q1
$11.6M Sell
126,090
-5,536
-4% -$499K 1.11% 22
2015
Q4
$13.4M Buy
131,626
+5,039
+4% +$524K 1.15% 21
2015
Q3
$12.2M Buy
126,587
+94,407
+293% +$10.5M 1.13% 19
2015
Q2
$3.71M Buy
+32,180
New +$3.52M 0.31% 102

Other funds holding GILD

Robeco Schweiz's GILD Position: Q1 2021 in Review

Robeco Schweiz sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 138,769 shares — an estimated $8.09M sold.

Robeco Schweiz first reported a position in GILD in Q2 2015 and held it in 23 quarters. The position peaked at $20.6M in Q1 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Robeco Schweiz reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Robeco Schweiz sold 138,769 Gilead Sciences shares in Q1 2021, an estimated $8.09M.
  • Robeco Schweiz first reported a position in Gilead Sciences in Q2 2015 and held it in 23 quarters.
  • Robeco Schweiz's Gilead Sciences position peaked at $20.6M in Q1 2020.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Robeco Schweiz's 13F filing for Q1 2021, filed 4 May 2021.